Autoimmune hepatitis, HLA and extended haplotypes

Autoimmunity Reviews

Volumn 10, Issue 4, 2011, Pages 189-193

  Oliveira, Lea Campos ^a   Porta, Gilda ^a   Marin, Maria Lucia C ^a   Bittencourt, Paulo Lisboa ^b   Kalil, Jorge ^a,c   Goldberg, Anna Carla ^c,d  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Hospital Portugues   (Brazil)

^c Instituto de Investigac ão em Imunologia Instituto Nacional de Ciência e Tecnologia INCT   (Brazil)

^d HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

Author keywords

Autoimmune hepatitis; Extended MHC haplotypes; Genetic susceptibility; HLA DR

Indexed keywords

HLA DR ANTIGEN;

AUTOIMMUNE HEPATITIS; DNA POLYMORPHISM; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HLA SYSTEM; HUMAN; PATHOPHYSIOLOGY; REVIEW;

EID: 79951855633     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2010.09.024     Document Type: Review

References (42)

1. Czaja A.J. Autoimmune hepatitis. Evolving concepts and treatment strategies. Dig Dis Sci 1995, 40:435-456.
2. Mieli-Vergani G., Heller S., Jara P., Vergani D., Chang M.H., Fujisawa T., et al. Autoimmune hepatitis. J Pediatr Gastroenterol Nutr 2009, 49:158-164.
3. Teufel A., Weinmann A., Kahaly G.J., Centner C., Piendl A., Worns M., et al. Concurrent autoimmune diseases in patients with autoimmune hepatitis. J Clin Gastroenterol 2010, 44:208-213.
4. Bittencourt P.L., Farias A.Q., Porta G., Cancado E.L., Miura I., Pugliese R., et al. Frequency of concurrent autoimmune disorders in patients with autoimmune hepatitis: effect of age, gender, and genetic background. J Clin Gastroenterol 2008, 42:300-305.
5. Alvarez F., Berg P.A., Bianchi F.B., Bianchi L., Burroughs A.K., Cancado E.L., et al. International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999, 31:929-938.
6. Hennes E.M., Zeniya M., Czaja A.J., Pares A., Dalekos G.N., Krawitt E.L., et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 2008, 48:169-176.
7. Gabbiani G., Ryan G.B., Lamelin J.P., Vassalli P., Majno G., Bouvier C.A., et al. Human smooth muscle autoantibody. Its identification as antiactin antibody and a study of its binding to "nonmuscular" cells. Am J Pathol 1973, 72:473-488.
8. Soares A., Cunha R., Rodrigues F., Ribeiro H. Smooth muscle autoantibodies with F-actin specificity. Autoimmun Rev 2009, 8:713-716.
9. Manns M.P., Johnson E.F., Griffin K.J., Tan E.M., Sullivan K.F. Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1. J Clin Invest 1989, 83:1066-1072.
10. Lapierre P., Hajoui O., Homberg J.C., Alvarez F. Formiminotransferase cyclodeaminase is an organ-specific autoantigen recognized by sera of patients with autoimmune hepatitis. Gastroenterology 1999, 116:643-649.
11. Czaja A.J., Shums Z., Norman G.L. Frequency and significance of antibodies to soluble liver antigen/liver pancreas in variant autoimmune hepatitis. Autoimmunity 2002, 35:475-483.
12. Fainboim L., Canero Velasco M.C., Marcos C.Y., Ciocca M., Roy A., Theiler G., et al. Protracted, but not acute, hepatitis A virus infection is strongly associated with HLA-DRB*1301, a marker for pediatric autoimmune hepatitis. Hepatology 2001, 33:1512-1517. Baltimore, Md.
13. Muratori L., Lenzi M., Ma Y., Cataleta M., Mieli-Vergani G., Vergani D., et al. Heterogeneity of liver/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease. Gut 1995, 37:406-412.
14. Zignego A.L., Piluso A., Giannini C. HBV and HCV chronic infection: autoimmune manifestations and lymphoproliferation. Autoimmun Rev 2008, 8:107-111.
15. Krawitt E.L. Autoimmune hepatitis. N Engl J Med 1996, 334:897-903.
16. Lau A.H., Thomson A.W. Dendritic cells and immune regulation in the liver. Gut 2003, 52:307-314.
17. Crispe I.N. Hepatic T cells and liver tolerance. Nat Rev Immunol 2003, 3:51-62.
18. Mackay I.R. Hepatoimmunology: a perspective. Immunol Cell Biol 2002, 80:36-44.
19. Klugewitz K., Blumenthal-Barby F., Schrage A., Knolle P.A., Hamann A., Crispe I.N. Immunomodulatory effects of the liver: deletion of activated CD4+ effector cells and suppression of IFN-gamma-producing cells after intravenous protein immunization. J Immunol 2002, 169:2407-2413.
20. Limmer A., Ohl J., Kurts C., Ljunggren H.G., Reiss Y., Groettrup M., et al. Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance. Nat Med 2000, 6:1348-1354.
21. Onoe T., Ohdan H., Tokita D., Shishida M., Tanaka Y., Hara H., et al. Liver sinusoidal endothelial cells tolerize T cells across MHC barriers in mice. J Immunol 2005, 175:139-146.
22. Goldberg A.C., Bittencourt P.L., Oliveira L.C., Ramasawmy R., Marin M.L., Palacios S.A., et al. Autoimmune hepatitis in Brazil: an overview. Scand J Immunol 2007, 66:208-216.
23. Bendelac A., Savage P.B., Teyton L. The Biology of NKT Cells. Annu Rev Immunol 2007, 25:297-336.
24. De Biasio M.B., Periolo N., Avagnina A., Garcia de Davila M.T., Ciocca M., Goni J., et al. Liver infiltrating mononuclear cells in children with type 1 autoimmune hepatitis. J Clin Pathol 2006, 59:417-423.
25. Longhi M.S., Hussain M.J., Mitry R.R., Arora S.K., Mieli-Vergani G., Vergani D., et al. Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis. J Immunol 2006, 176:4484-4491.
26. Cookson S., Constantini P.K., Clare M., Underhill J.A., Bernal W., Czaja A.J., et al. Frequency and nature of cytokine gene polymorphisms in type 1 autoimmune hepatitis. Hepatology 1999, 30:851-856.
27. Seki T., Ota M., Furuta S., Fukushima H., Kondo T., Hino K., et al. HLA class II molecules and autoimmune hepatitis susceptibility in Japanese patients. Gastroenterology 1992, 103:1041-1047.
28. Pando M., Larriba J., Fernandez G.C., Fainboim H., Ciocca M., Ramonet M., et al. Pediatric and adult forms of type I autoimmune hepatitis in Argentina: evidence for differential genetic predisposition. Hepatology 1999, 30:1374-1380.
29. Bittencourt P.L., Goldberg A.C., Cancado E.L., Porta G., Carrilho F.J., Farias A.Q., et al. Genetic heterogeneity in susceptibility to autoimmune hepatitis types 1 and 2. Am J Gastroenterol 1999, 94:1906-1913.
30. Goldberg A.C., Bittencourt P.L., Mougin B., Cancado E.L., Porta G., Carrilho F., et al. Analysis of HLA haplotypes in autoimmune hepatitis type 1: identifying the major susceptibility locus. Hum Immunol 2001, 62:165-169.
31. Duarte-Rey C., Pardo A.L., Rodriguez-Velosa Y., Mantilla R.D., Anaya J.M., Rojas-Villarraga A. HLA class II association with autoimmune hepatitis in Latin America: a meta-analysis. Autoimmun Rev 2009, 8:325-331.
32. Czaja A.J., Carpenter H.A., Moore S.B. HLA DRB1*13 as a risk factor for type 1 autoimmune hepatitis in North American patients. Dig Dis Sci 2008, 53:522-528.
33. Czaja A.J. Genetic factors affecting the occurrence, clinical phenotype, and outcome of autoimmune hepatitis. Clin Gastroenterol Hepatol 2008, 6:379-388.
34. Djilali-Saiah I., Fakhfakh A., Louafi H., Caillat-Zucman S., Debray D., Alvarez F. HLA class II influences humoral autoimmunity in patients with type 2 autoimmune hepatitis. J Hepatol 2006, 45:844-850.
35. Okamoto K., Makino S., Yoshikawa Y., Takaki A., Nagatsuka Y., Ota M., et al. Identification of I kappa BL as the second major histocompatibility complex-linked susceptibility locus for rheumatoid arthritis. Am J Hum Genet 2003, 72:303-312.
36. Badenhoop K., Schwarz G., Trowsdale J., Lewis V., Usadel K.H., Gale E.A., et al. TNF-alpha gene polymorphisms in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1989, 32:445-448.
37. de Bakker P.I., McVean G., Sabeti P.C., Miretti M.M., Green T., Marchini J., et al. A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nat Genet 2006, 38:1166-1172.
38. Dorak M.T., Shao W., Machulla H.K., Lobashevsky E.S., Tang J., Park M.H., et al. Conserved extended haplotypes of the major histocompatibility complex: further characterization. Genes Immun 2006, 7:450-467.
39. Czaja A.J., Cookson S., Constantini P.K., Clare M., Underhill J.A., Donaldson P.T. Cytokine polymorphisms associated with clinical features and treatment outcome in type 1 autoimmune hepatitis. Gastroenterology 1999, 117:645-652.
40. Bittencourt P.L., Palacios S.A., Cancado E.L., Porta G., Drigo S., Carrilho F.J., et al. Autoimmune hepatitis in Brazilian patients is not linked to tumor necrosis factor alpha polymorphisms at position -308. J Hepatol 2001, 35:24-28.
41. Bayley J.P., Ottenhoff T.H., Verweij C.L. Is there a future for TNF promoter polymorphisms? Genes Immun 2004, 5:315-329.
42. Koch W., Hoppmann P., Michou E., Jung V., Pfeufer A., Mueller J.C., et al. Association of variants in the BAT1-NFKBIL1-LTA genomic region with protection against myocardial infarction in Europeans. Hum Mol Genet 2007, 16:1821-1827.